Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Dialysate Variation in ICU Acute Kidney Injury
NCT03329313Phase 2Recruiting
- Sponsor
- CHU Montpellier
- Start
- Apr 2018
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute kidney injury (AKI) (2 arms), sponsored by CHU Montpellier. Primary endpoint: Fluid overload at 28 days. Started Apr 2018; status: recruiting.
02
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03329313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329313.